Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Healios Cash and Short Term Investments (Quarterly): 47.67M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 47.67M |
September 30, 2023 | 64.17M |
June 30, 2023 | 47.83M |
March 31, 2023 | 53.71M |
December 31, 2022 | 55.86M |
September 30, 2022 | 48.09M |
June 30, 2022 | 89.09M |
March 31, 2022 | 110.61M |
December 31, 2021 | 131.44M |
September 30, 2021 | 149.99M |
June 30, 2021 | 101.61M |
March 31, 2021 | 111.31M |
December 31, 2020 | 135.00M |
September 30, 2020 | 138.58M |
June 30, 2020 | 143.29M |
March 31, 2020 | 160.99M |
December 31, 2019 | 168.01M |
September 30, 2019 | 176.28M |
Date | Value |
---|---|
June 30, 2019 | 80.71M |
March 31, 2019 | 92.33M |
December 31, 2018 | 106.68M |
September 30, 2018 | 118.81M |
June 30, 2018 | 133.79M |
March 31, 2018 | 136.58M |
December 31, 2017 | 168.88M |
September 30, 2017 | 145.26M |
June 30, 2017 | 143.40M |
March 31, 2017 | 82.65M |
December 31, 2016 | 67.29M |
September 30, 2016 | 83.71M |
June 30, 2016 | 88.73M |
March 31, 2016 | 74.27M |
December 31, 2015 | 76.33M |
September 30, 2015 | 79.63M |
June 30, 2015 | 71.58M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
47.67M
Minimum
Dec 2023
176.28M
Maximum
Sep 2019
106.01M
Average
110.61M
Median
Mar 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 2.251B |
Nxera Pharma Co Ltd | 350.16M |
PeptiDream Inc | 138.37M |
Stemcell Holdings Inc | 5.116M |
AnGes Inc | 29.50M |